PRESS RELEASE published on 07/23/2024 at 07:30, 1 year 8 months ago Inside Information / News release on accounts, results GenSight Biologics reports cash position of €6.9 million as of June 30, 2024, with potential over 100 vials available upon Q3 resumption of early access program. Company confirms sufficient working capital and successful blending step for LUMEVOQ drug product Working Capital Business Update Cash Position GenSight Biologics LUMEVOQ Drug Product
PRESS RELEASE published on 07/23/2024 at 07:30, 1 year 8 months ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa position de trésorerie au 30 juin 2024, et fait le point sur ses activités. La trésorerie s'élève à 6,9 millions d'euros, suffisante jusqu'au quatrième trimestre 2024 Trésorerie GenSight Biologics Thérapies Géniques Activités LUMEVOQ
BRIEF published on 07/11/2024 at 07:35, 1 year 8 months ago GenSight Biologics Launches Newsletter for Retail Investors Financial Updates Gene Therapy Retail Investors LUMEVOQ® Optogenetics
BRIEF published on 07/11/2024 at 07:35, 1 year 8 months ago GenSight Biologics lance une newsletter destinée aux investisseurs particuliers Investisseurs Particuliers Thérapie Génique LUMEVOQ® Optogénétique Mises À Jour Financières
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 8 months ago Inside Information / Other news releases GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website Subscription Retail Investors Newsletter French GenSight Biologics
PRESS RELEASE published on 07/11/2024 at 07:30, 1 year 8 months ago Informations privilégiées / Autres communiqués GenSight Biologics lance une lettre d'information destinée aux investisseurs particuliers en France, présentant des actualités et des informations sur la société et ses projets innovants Investisseurs Particuliers GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Lettre D'information
BRIEF published on 06/20/2024 at 07:35, 1 year 9 months ago GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates Gene Therapy Operational Update GenSight Biologics Financial Negotiation
BRIEF published on 06/20/2024 at 07:35, 1 year 9 months ago GenSight Biologics renégocie ses obligations financières et fournit des mises à jour opérationnelles Thérapie Génique Mise À Jour Opérationnelle Produits Biologiques GenSight Négociation Financière
PRESS RELEASE published on 06/20/2024 at 07:30, 1 year 9 months ago Inside Information / Other news releases GenSight Biologics renegotiates financial obligations and provides operational updates, with successful capital increases enhancing short-term flexibility Financial Obligations Operational Updates GenSight Biologics Capital Increases Gene Therapies
BRIEF published on 06/04/2024 at 07:35, 1 year 9 months ago GenSight Biologics to Present at Key Medical Conferences in 2024 Gene Therapy GenSight Biologics Medical Conferences 2024 LUMEVOQ® LHON
Published on 03/24/2026 at 18:55, 3 hours 13 minutes ago Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 8 hours 38 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 8 hours 38 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 9 hours 33 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 9 hours 35 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 21:08, 1 hour ago Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Published on 03/24/2026 at 19:49, 2 hours 18 minutes ago EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 2 hours 26 minutes ago ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 3 hours 2 minutes ago WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 3 hours 28 minutes ago EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 17:46, 4 hours 21 minutes ago NRJ GROUP - Press release annual results 2025
